Answers are grounded in this paper and cite their sources.
This study suggests that FOLFOX second-line therapy offered interesting efficacy results with an acceptable toxicity profile in metastatic PC patients with a good PS.
No takes yet. Share an insight, caveat, or question.
Zaanan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: